How may we assist you?

  • Meet Pepscan at CPhI Worldwide 2021

    The Pepscan team is excited to meet you in person at the upcoming edition of CPhI Worldwide in Milan, Italy (November 9-11). We will be at booth 18J51 and would be happy to discuss how Pepscan combines smart peptide science and flexible manufacturing capabilities that conform to GMP. Over the last few years, we have made tremendous efforts and investments in building our GMP capabilities at our Dutch all-in-one facility. Starting from GMP production of neoantigen vaccines at microgram scale, …

  • Pepscan joins Biologics UK

    Meet us at Biologics UK in London! We’re very excited to attend our first in-person event in 2021 and to share our experience in clinically-applied radiopharmaceutical peptides. Visit us at our booth (4) or reach out to Zoran Medic to schedule an appointment or for more info.

  • Ardigen, ImmuMap and Pepscan kick-off collaboration for T-cell receptor discovery

    Ardigen. ImmuMap and Pepscan recently kicked off their collaboration. The research study, called Creating an innovative AI-based (artificial intelligence) in silico technology TCRact to launch a new service for designing and optimizing T-cell receptors (TCR) for use in cancer immunotherapies, is partly funded through a grant obtained by Ardigen from the EU’s European Regional Development Fund under the Intelligent Development Program.  The scope of the collaboration will revolve around the identification of T-cell receptors reactive towards newly identified neoantigens of …

  • Pepscan expands capacity at multiple gram scales to keep delivering optimal flexibility for its (GMP) customers

    Pepscan’s technicians recently installed and qualified a new fully automated two-liter peptide synthesizer enabling production of 10–30 gram batches. This new piece of equipment ensures Pepscan can keep providing its clients optimal flexibility when synthesizing peptides for their clinical or research purposes; it also allows Pepscan to meet the rapidly increasing demand from clients who need peptides in  an upscaling trajectory for their clinical trials. “In the past our peptide production capacity has at times bottlenecked, preventing us from delivering to …

  • Passion for peptides – The people behind Pepscan

    “I’m always looking for ways to improve,” says Upendo Syikilili. Upendo has been working as a Crude Library Technician for over a year and is one of Pepscan’s employees who recently took part in Pepscan’s Lean Six Sigma Yellow Belt training. “For us continuous improvement is an important tool to deliver the highest quality to customers and at the same time stay flexible in our operational organization. My colleagues and I focus on ways to make our processes more efficient …

  • Viewpoint Molecular Targeting® Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

    – Companies forge relationship to accelerate peptide drug discovery for next-generation radiopharmaceuticals – – Pepscan brings proprietary world-leading peptide drug discovery expertise and technologies – – Viewpoint to apply expertise in radiopharmaceuticals, chelation technologies and bioconjugate chemistry to accelerate the pace of discovery to clinic-ready radiopharmaceuticals Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the “Company”), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced it has entered into a collaborative partnership with Netherlands-based Pepscan …

  • CLIPS™ technology: “Powerful, elegant, and full of potential”

    Mastering peptides can enable life-improving breakthroughs in the life sciences. Constraining peptides in well-defined 3D conformations is a powerful method. Pepscan developed a surprisingly simple, yet elegant principle to do so. Its CLIPS™ technology can create mono-, bi- and, in combination with click chemistry, even up to hexa-cyclic formats. “A super powerful tool. We know this from our own work, and it has been proven as well by Bicycle Therapeutics, to whom we granted a global CLIPS™ Technology license for …

  • Pepscan SARS-CoV-2 Antibody Profiling Services

    Use our peptide array technology, which is built on 25 years of experience, to provide novel insights! Therapeutic antibody recognition of SARS-CoV-2 mutations Confirming vaccine ability to induce an antibody response against SARS-CoV-2 mutations Profiling of main antibody response to canonical SARS-CoV-2 sequences and recent mutations   Schedule a call with our experts for more information: Dennis Flierman, PhD – Director of Epitope Mapping Dennis is an experienced professional with a fundamental biomedical sciences background and experience in immunology, structural …

  • Passion for peptides – Full focus on quality and smart science

    In Pepscan’s cleanroom, peptides are tailored to our customer’s needs and specifications. Through streamlined project management and strict GMP-compliant procedures, rapid and high-quality clinical peptide manufacturing is ensured. Dennis Lub is one of the members of Pepscan’s cleanroom team. “Together with the other team members, we make sure that all manufacturing steps performed in the cleanroom, like purification with dedicated columns, freeze drying, and aliquoting, comply with our procedures, meet our quality standards, and are documented in batch records with …

  • Growing customer base – Expansion needs

    Our unique, small-scale, and lean pharmaceutical-standard processes give us agility. An important reason why Pepscan has become the preferred supplier of peptide products and related services for an increasing number of companies. Recently, a new PGS15 safety storage for our chemicals was installed next to our existing facility. This new storage brings many advantages: expands our storage capacity increases quality storage conditions, as the new storage is fully temperature controlled enable synthesis lab expansion by freeing up space reduces risk …

We use cookies to ensure that we give you the best experience on our website. We also use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the Pepscan website. However, if you would like to, you can change your cookie settings at any time in your browser.
Cookie Policy
Find out more
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Accept All Cookies